For all investor queries, please contact info@vasomune.com.
Latest News
Vasomune Therapeutics and AnGes, Inc. enter into a Multi-Million Dollar Global Co-Development Agreement to Advance an Innovative Platform Targeting Vascular Leakage
Tokyo, Japan and Toronto, Ontario, July 31, 2018 (GLOBE NEWSWIRE) — Vasomune Therapeutics (“Vasomune”), a Toronto-based spin-out from Sunnybrook Research Institute and MaRS Innovation, and AnGes, Inc.
August 31, 2018
No Comments
36th Annual JPM Healthcare Conference
In 2018 Vasomune Therapeutics will be at the 36TH ANNUAL JPM HEALTHCARE CONFERENCE, San Francisco, California
December 25, 2017
No Comments
A New Flu Drug Works Astoundingly Well—By Not Targeting the Flu at All
A New Flu Drug Works Astoundingly Well—By Not Targeting the Flu at All. Continue reading at Motherboard Vice.
June 13, 2015
No Comments
Preventing the flu: Researchers looking for a new approach
Lifetime: New approach to fighting influenza Advertise on CTVNews.ca
June 5, 2015
No Comments